Oarsman Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.7M | Sell |
|
|||||
|
2025
Q2 | $1.84M | Buy |
|
|||||
|
2025
Q1 | $2.17M | Buy |
|
|||||
|
2024
Q4 | $1.48M | Buy |
|
|||||
|
2024
Q3 | $1.34M | Buy |
|
|||||
|
2024
Q2 | $1.03M | Sell |
|
|||||
|
2024
Q1 | $1.57M | Buy |
|
|||||
|
2023
Q4 | $1.44M | Buy |
|
|||||
|
2023
Q3 | $1.59M | Buy |
|
|||||
|
2023
Q2 | $1.46M | Sell |
|
|||||
|
2023
Q1 | $1.6M | Buy |
|
|||||
|
2022
Q4 | $1.64M | Buy |
|
|||||
|
2022
Q3 | $1.58M | Sell |
|
|||||
|
2022
Q2 | $1.75M | Sell |
|
|||||
|
2022
Q1 | $1.79M | Buy |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $1.44M | Sell |
|
|||||
|
2021
Q2 | $1.69M | Sell |
|
|||||
|
2021
Q1 | $2.07M | Sell |
|
|||||
|
2020
Q4 | $2.38M | Buy |
|
|||||
|
2020
Q3 | $2.3M | Buy |
|
|||||
|
2020
Q2 | $2.14M | Buy |
|
|||||
|
2020
Q1 | $858K | Buy |
|
|||||
|
2019
Q4 | $283K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $220K | Sell |
|
|||||
|
2018
Q2 | $208K | Sell |
|
|||||
|
2018
Q1 | $249K | Buy |
|
|||||
|
2017
Q4 | $230K | Sell |
|
|||||
|
2017
Q3 | $241K | Hold |
|
|||||
|
2017
Q2 | $210K | Buy |
|
|||||
|
2017
Q1 | $205K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $204K | Sell |
|
|||||
|
2016
Q2 | $318K | Buy |
|
|||||
|
2016
Q1 | $275K | Hold |
|
|||||
|
2015
Q4 | $296K | Hold |
|
|||||
|
2015
Q3 | $255K | Hold |
|
|||||
|
2015
Q2 | $286K | Sell |
|
|||||
|
2015
Q1 | $285K | Hold |
|
|||||
|
2014
Q4 | $261K | Hold |
|
|||||
|
2014
Q3 | $226K | Hold |
|
|||||
|
2014
Q2 | $215K | Hold |
|
|||||
|
2014
Q1 | $230K | Buy |
|
|||||
|
2013
Q4 | $229K | Buy |
|